Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 2-5 September 2024

EMA recommends measures to minimise serious outcomes of known side effect with painkiller metamizoleProduct information to be updated to raise awareness of known risk of…, Agenda Agenda of the PRAC meeting 2-5 September 2024DraftReference Number: EMA/PRAC/323875/2024 English (EN…, PRAC statistics: September 2024 , PRAC statistics: September 2024 English (EN) (33.15 MB – PDF)First published: 06/09/2024View, Glossary Safety signal assessments. A safety signal is information which suggests a new potentially causal association, or a new aspect of a known association…, Ongoing referrals ProcedureStatusUpdateMetamizole containing medicinal products – referralUnder evaluationPRAC continued its assessment